Fidson Healthcare Plc, at the weekend, received shareholders’ nod to raise additional N6billion for business expansion and other growth initiatives.The company’s shareholders also approved the payment of N75million total dividends…
According to Fidson, the dividend warrant will be posted to members whose names appeared in the register of members at the close of business on June 23, 2017.
Reviewing its performance during its 18th yearly general meeting in Lagos, the Chairman, Felix Ohiwerei, explained that the firm completed its new factory towards the end of 2016, adding that the fresh fund would boost its working capital, which was affected by currency depreciation and other macro-economic challenges.
He explained further that the new capital would be sourced through public offering, rights issue, private placement of shares or other methods in the ratio and terms including pricing of the securities, conditions, and dates to be determined by the directors.
On their future outlook, Ohiwerei said: “the completion of our new factory and the concentration of production on one site is an important milestone for the company. The board is confident that the company is in a very good position to remain a leading player in the industry.
The board is also confident that the company will continue to yield good returns to the shareholders. Through the new infusion lines that we recently added, new products have been introduced. ’’
These products have been well received by the market.”The company’s profit after tax for the year 2016 dropped to N316.76million from N744.39 million recorded in 2015, while turnover stood at N7.66 billion, representing a decline of seven per cent when compared with N8.210 billion recorded in 2015.
Gross profit was N4.06 compared with N5.35 billion made in the preceding year, showing a decline of N24.21 percent. Operating profit also declined to N1.09 billion from N1.52 billion recorded in 2015.